What is Ginkgo Bioworks's remainder of fiscal year 2024?

Ginkgo Bioworks (DNA) reported remainder of fiscal year 2024 of $12.4M in Q1 2026.

How has Ginkgo Bioworks's remainder of fiscal year 2024 changed year-over-year?

Ginkgo Bioworks's remainder of fiscal year 2024 decreased by 12.9% year-over-year, from $14.24M to $12.4M.

Ginkgo Bioworks DNA Remainder of Fiscal Year 2024

Remainder of Fiscal Year 2024 at other companies

AzentaAZTA

——

Maravai LifeSciences Holdings, Inc.MRVI

——

Bio-Rad LaboratoriesBIO

——

RevvityRVTY

——

Agilent TechnologiesA

——

ClearPoint NeuroCLPT

——

Other financials

Income statement

See full

Revenue$19.5M-49.1%

Gross profit$16.4M-52.0%

Operating income-$71.4M+11.9%

Net income-$82.6M+9.2%

EPS (diluted)-$1.42+27.6%

Balance sheet

See full

Cash & equivalents$188.7M-46.9%

Total debt$410.7M-5.5%

Total equity$443.2M-31.6%

Total assets$1.0B-20.1%

Cash flow

See full

Operating cash flow-$46.7M+9.4%

CapEx$1.9M-74.6%

Free cash flow-$48.6M+17.8%

Valuation

See full

Market cap$625.16M+24.6%

Enterprise value$847.19M+45.9%

P/S4.4×+2.2×

Profitability

See full

Operating margin-210.7%+7.6pp

Net margin-215.4%+8.3pp

FCF margin-119%-21.2pp

Returns & leverage

See full

Return on equity-55.8%-1.8pp

Debt / equity0.9×+0.3×

Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's remainder of fiscal year 2024.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ginkgo Bioworks's remainder of fiscal year 2024?: Ginkgo Bioworks (DNA) reported remainder of fiscal year 2024 of $12.4M in Q1 2026.
How has Ginkgo Bioworks's remainder of fiscal year 2024 changed year-over-year?: Ginkgo Bioworks's remainder of fiscal year 2024 decreased by 12.9% year-over-year, from $14.24M to $12.4M.